Table A1.
Mood, Anxiety, and Fatigue Self-Rating Raw Scores*
| Time-Point | Measure | CTx+ (n = 16) |
CTx− (n = 12) |
Control (n = 15) |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | No. Above Threshold* | Mean | SD | No. Above Threshold* | Mean | SD | No. Above Threshold* | ||
| Baseline | CES-D | 8.7 | 8.2 | 2 | 5.7 | 6.6 | 1 | 4.9 | 4.7 | 0 |
| STAI-S | 30.5 | 10.7 | 2 | 28.8 | 13.1 | 1 | 25.9 | 7.1 | 0 | |
| FSI | 3.2 | 2.0 | 8 | 3.2 | 1.7 | 7 | 3.3 | 1.8 | 9 | |
| M1 | CES-D | 10.4 | 10.4 | 3 | 6.1 | 5.7 | 1 | 4.6 | 4.9 | 0 |
| STAI-S | 31.5 | 13.9 | 2 | 27.1 | 9.2 | 1 | 27.4 | 8.9 | 1 | |
| FSI | 3.7 | 2.1 | 10 | 2.9 | 1.8 | 7 | 2.7 | 1.4 | 5 | |
| Y1 | CES-D | 6.6 | 6.0 | 3 | 7.5 | 10.4 | 1 | 5.2 | 9.7 | 1 |
| STAI-S | 27.6 | 9.1 | 1 | 28.3 | 11.3 | 1 | 26.4 | 7.7 | 0 | |
| FSI | 3.0 | 2.2 | 6 | 3.4 | 1.7 | 7 | 2.4 | 1.3 | 5 | |
NOTE. There were no significant between-group differences at any time-point or any group-by-time interactions (P > .05).
Abbreviations: CES-D, Center for Epidemiologic Studies-Depression Scale (raw score); CTx+, patients treated with chemotherapy; CTx−, patients not treated with chemotherapy; FSI, Fatigue Symptom Inventory (composite raw score); M1, 1 month after completion of chemotherapy; SD, standard deviation; STAI-S, State-Trait Anxiety Inventory-State Scale (raw score); Y1, 1 year after M1 visit.
*
Thresholds for significant symptomatology: CES-D raw score ≥ 16, STAI-S T score ≥ 65, FSI composite raw score ≥ 3.